// App-Quantinova.ai

1372 : AllergoOncology: Study of potential hypersensitivity to an anti‐tumor IgE therapeutic candidate in a diverse cohort of ovarian cancer patients using a basophil activation test

Researchers

Presenter

  • Bax HJ

Principal Investigators

  • Stavraka C

  • Khiabany A

  • Pellizzari G

  • Chan Wah Hak C

  • Robinson A

  • Ilieva KM

  • Woodman N

  • Naceur-Lombardelli C

  • Gillett C

  • Pinder S

  • Gould HJ

  • Corrigan CJ

  • Till SJ

  • Katugampola S

  • Barton C

  • Winship A

  • Ghosh S

  • Montes A

  • Josephs DH

  • Spicer JF

  • Karagiannis SN

Medical Centers

  • St. John's Institute of Dermatology, London, United Kingdom

  • School of Cancer & Pharmaceutical Sciences, London, United Kingdom

  • School of Basic & Medical Biosciences, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Departments of Medical Oncology and Clinical Oncology, London, United Kingdom

  • Guy’s and St. Thomas’ NHS Foundation Trust

  • School of Cancer & Pharmaceutical Sciences

  • Departments of Medical Oncology and Clinical Oncology

  • Breast Cancer Now Research Unit, London, United Kingdom

  • Asthma UK Centre

  • Allergic Mechanisms in Asthma, London, United Kingdom

  • Department of Respiratory Medicine and Allergy and School of Immunology and Microbial Sciences, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • Folate Receptor 1

  • Immunoglobulin E

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved